X-Received: by 2002:a05:622a:1313:b0:31d:32e4:bd59 with SMTP id v19-20020a05622a131300b0031d32e4bd59mr17244223qtk.685.1656933437126;
Mon, 04 Jul 2022 04:17:17 -0700 (PDT)
X-Received: by 2002:aca:a896:0:b0:337:ac7c:5e3e with SMTP id
r144-20020acaa896000000b00337ac7c5e3emr5266894oie.40.1656933436883; Mon, 04
Jul 2022 04:17:16 -0700 (PDT)
Path: i2pn2.org!i2pn.org!usenet.blueworldhosting.com!feed1.usenet.blueworldhosting.com!peer03.iad!feed-me.highwinds-media.com!news.highwinds-media.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: comp.unix.shell
Date: Mon, 4 Jul 2022 04:17:16 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=104.223.104.235; posting-account=hkCnjwoAAAD931FDYXyewH5MrRYaKfqN
NNTP-Posting-Host: 104.223.104.235
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <e588dd84-d8bf-40ec-87c7-3f6e59353350n@googlegroups.com>
Subject: (PDF) Pharmaceutical Substances, Syntheses, Patents 5th Edition by
Axel Kleemann
From: hesterho...@gmail.com (Hester Holt)
Injection-Date: Mon, 04 Jul 2022 11:17:17 +0000
Content-Type: text/plain; charset="UTF-8"
X-Received-Bytes: 1287